CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 52:15 Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences 10 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 29:09 PTC Therapeutics — EMFLAZA® Landscape in 2024 10 months ago Care Webinars,Webinars emflaza,ptc therapeutics 53:59 Dyne Therapeutics — Advancing DYNE-251, an Investigational Medicine for DMD 11 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:00:58 Navigating Steroid Choices: Understanding the Process, Pathways, and Policies 11 months ago Care Webinars,Webinars steroids 1:03:41 Community Update with Solid Biosciences on the New INSPIRE DUCHENNE Clinical Study of SGT-003 1 year ago Research & Clinical Trial Webinars,Webinars gene therapy,sgt-003,solid biosciences 59:54 Overview of Topline Results from Phase 3 EMBARK Study 1 year ago Research & Clinical Trial Webinars,Webinars sarepta 25:01 Advocating for Access: Overview of Medicaid DUR and P&T Meetings 1 year ago Care Webinars,Webinars feature,insurance,medicaid 54:28 Capricor Therapeutics: CAP-1002 HOPE-3 Program Update 1 year ago Research & Clinical Trial Webinars,Webinars capricor «12345…25»Page 3 of 25
by: Parent Project Muscular Dystrophy
